Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells

F Fukamauchi, PA Saunders, C Hough and DM Chuang

Section on Molecular Neurobiology, National Institute of Mental Health, Bethesda, Maryland 20892.

Cerebellar granule cells express m2- and m3-muscarinic acetylcholine receptors (mAChRs) and their corresponding mRNA with m3-mAChR being the predominant receptor subtype. After stimulation with the mAChR agonist, carbachol, m2- and m3-mAChR mRNA levels were decreased in a time- and concentration-dependent manner with the maximal down-regulation at 2 and 8 hr, respectively. Immunoprecipitation studies revealed that amounts of m2- and m3-mAChR protein also decreased at 8 and 24 hr, respectively. The carbachol-induced down-regulation of m3-mAChR mRNA was associated with a decrease in the transcription rate, but a substantial enhancement of the mRNA stability. Upon removal of carbachol after treatment for 8 hr, the levels of m3-mAChR mRNA and mAChR binding sites returned to their original values with a t1/2 of approximately 80 min and 6 hr, respectively. The carbachol-elicited loss of m2- and m3-mAChR mRNA was blocked by their corresponding receptor subtype-specific antagonists, AF-DX 116 (m2-selective) and 4- diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP) (m3-selective), and was concurrent with an increase in c-fos mRNA levels. Exposure of granule cells to the nonselective mAChR antagonist, atropine, caused a time- and concentration-dependent increase in the level of both m2- and m3-mAChR mRNA and mAChR binding sites. At 24 hr, immunoprecipitable m3- mAChR protein was predominantly increased. The atropine-induced up- regulation of m3-mAChR mRNA was concurrent with a marked enhancement of the mRNA stability and its transcription rate. The elevated levels of m3-mAChR mRNA and binding sites declined to their untreated values after the removal of atropine. Treatment with AF-DX 116 and 4-DAMP also produced an increase in the level of m2- and m3-mAChR mRNA and their corresponding immunoprecipitable receptor protein. These results demonstrate that the mAChR agonist and antagonist induce a down- and up- regulation of mAChR expression, respectively, through receptor-mediated mechanisms in cerebellar granule cells. Moreover, at least for m3-mAChR mRNA, the agonist- and antagonist-induced effects are reversible and associated with corresponding changes in the transcription rate of this receptor mRNA species.

Volume 44, Issue 5, pp. 940-949, 11/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				T. L. Limke, J. J. Bearss, and W. D. Atchison Acute Exposure to Methylmercury Causes Ca2+ Dysregulation and Neuronal Death in Rat Cerebellar Granule Cells through an M3 Muscarinic Receptor-Linked Pathway Toxicol. Sci., July 1, 2004; 80(1): 60 - 68. [Abstract] [Full Text] [PDF]

				Y. Takayasu, M. Iino, N. Furuya, and S. Ozawa Muscarine-Induced Increase in Frequency of Spontaneous EPSCs in Purkinje Cells in the Vestibulo-Cerebellum of the Rat J. Neurosci., July 16, 2003; 23(15): 6200 - 6208. [Abstract] [Full Text] [PDF]

				C. K. Billington and R. B. Penn m3 Muscarinic Acetylcholine Receptor Regulation in the Airway Am. J. Respir. Cell Mol. Biol., March 1, 2002; 26(3): 269 - 272. [Full Text] [PDF]

				R.-W. Chen, P. A. Saunders, H. Wei, Z. Li, P. Seth, and D.-M. Chuang Involvement of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and p53 in Neuronal Apoptosis: Evidence That GAPDH Is Upregulated by p53 J. Neurosci., November 1, 1999; 19(21): 9654 - 9662. [Abstract] [Full Text] [PDF]

				M. Pelat, P. Verwaerde, C. Merial, J. Galitzky, M. Berlan, J.-L. Montastruc, and J.-M. Senard Impaired Atrial M2-Cholinoceptor Function in Obesity-Related Hypertension Hypertension, November 1, 1999; 34(5): 1066 - 1072. [Abstract] [Full Text] [PDF]

				R. Maggio, P. Barbier, A. Colelli, F. Salvadori, G. Demontis, and G. U. Corsini G Protein-Linked Receptors: Pharmacological Evidence for the Formation of Heterodimers J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 251 - 257. [Abstract] [Full Text]

				R.-W. Chen and D.-M. Chuang Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression. A PROMINENT ROLE IN NEUROPROTECTION AGAINST EXCITOTOXICITY J. Biol. Chem., March 5, 1999; 274(10): 6039 - 6042. [Abstract] [Full Text] [PDF]

				O. Vögler, P. Krummenerl, M. Schmidt, K. H. Jakobs, and C. J. Van Koppen RhoA-Sensitive Trafficking of Muscarinic Acetylcholine Receptors J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 36 - 42. [Abstract] [Full Text]

				N. H. Lee and R. L. Malek Nerve Growth Factor Regulation of m4 Muscarinic Receptor mRNA Stability but Not Gene Transcription Requires Mitogen-activated Protein Kinase Activity J. Biol. Chem., August 28, 1998; 273(35): 22317 - 22325. [Abstract] [Full Text] [PDF]